This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Reported reason: Shortage of an active ingredient
Product Information
DEXTROAMP-AMPHETAMINE 5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.2640 per EA under NDC 70010011101. Its NADAC has been published 144 times since Aug 9, 2023.
FDA first approved this application on Dec 28, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAMINE 5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010011101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215771FDA Approved
12/28/2021
TE Code
AB
On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has been published 144 times since Aug 9, 2023, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2640 per EA |
|---|---|
| All-time high | $0.3259 (Sep 13, 2023) |
| All-time low | $0.1824 (Jul 17, 2024) |
| 52-week high | $0.2728 |
| 52-week low | $0.2386 |
| Median price | $0.2553 |
| Average price | $0.2541 |
| Largest weekly change | +37.0% (Aug 21, 2024) |
| Weeks tracked | 144 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMINE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMINE 5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.2640 per EA (NDC 70010011101), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMINE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has declined 11.8%. It has been tracked across 144 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMINE 5 MG TAB?
Since Aug 9, 2023, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has ranged from a low of $0.1824 (Jul 17, 2024) to a high of $0.3259 (Sep 13, 2023), with a median of $0.2553 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMINE 5 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMINE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMINE 5 MG TAB?
DEXTROAMP-AMPHETAMINE 5 MG TAB (NDC 70010011101) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMINE 5 MG TAB in shortage?
Yes — NDC 70010011101 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.